|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.308 SEK | +0.62% |
|
0.00% | +41.56% |
| 05-22 | Intervacc AB Completes Successful Evaluation of Us Strain of Strangles Pathogen Ahead of Clinical Trials | CI |
| 05-15 | Sweden's Intervacc Elects New Chair | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -5.91x | 2.28x | 0.32x | 19.78x | -5.52x | -4.25x | - | 45.86M | ||
| 34.14x | 6.31x | 0.84x | 8.68x | 26.92x | 27.54x | 0.05% | 56.98B | ||
| 20.2x | 3.86x | -2.17x | 6.2x | 13.51x | 15.71x | 1.5% | 53.58B | ||
| -44.73x | 60.08x | 0.76x | 14.86x | -43.31x | -46.68x | -.--% | 25.63B | ||
| -18.5x | 1.14x | 2.87x | 4.48x | -7.85x | -6.44x | -.--% | 23.51B | ||
| 24.36x | 2.38x | 1.77x | 4.79x | 12.56x | 15.04x | -.--% | 19.43B | ||
| 25.29x | 2.87x | -1.18x | 4.92x | 16.02x | 18.06x | -.--% | 18.12B | ||
| 49.34x | 12.65x | 0.44x | 20.07x | 51.69x | 47.42x | 0.11% | 16.46B | ||
| -495.91x | 20.35x | 10.06x | 34.06x | -3797.57x | -372.82x | -.--% | 14.13B | ||
| 17.96x | 5.1x | 1.25x | 5.22x | 12.19x | 13.39x | -.--% | 14.35B | ||
| -80.32x | 28.72x | 1.76x | 8.28x | -74.24x | -59.47x | -.--% | 12.91B | ||
| -13.64x | 160.48x | 0.66x | 3557.14x | -16.55x | -13.5x | -.--% | 12.01B | ||
| -26.51x | 27.32x | -0x | 24.66x | -31.36x | -25.37x | -.--% | 11.83B | ||
| -13.43x | -91.2x | 6.61x | 99.88x | -15.28x | -14.86x | -.--% | 11.69B | ||
| 3219.99x | 7.86x | -31.55x | 13.8x | 84.19x | 288.8x | -.--% | 11.13B | ||
| -21.59x | 8.28x | 10.99x | 803.7x | -18.86x | -18.77x | -.--% | 9.82B | ||
| -10.44x | - | -0.08x | - | - | - | - | 9.29B | ||
| -17.72x | 8.81x | 3.79x | 113.62x | -15.89x | -14.44x | - | 8.82B | ||
| 12.14x | 5.81x | 0.03x | 8.25x | 13.36x | 14.11x | -.--% | 9.05B | ||
| -7.03x | - | -0.14x | - | -7.21x | -6.63x | -.--% | 8.64B | ||
| Average | 132.38x | 15.17x | 0.35x | 264.02x | -200.17x | -7.53x | 0.1% | 17.37B | |
| Weighted average by Cap. | 86.85x | 14.13x | 0.28x | 169.38x | -154.34x | -3.09x | 0.26% |
- Stock Market
- Stocks
- IVACC Stock
- Sector Intervacc AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















